Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
962,5 USD | -0,39% | -0,57% | +9,59% |
Omzet 2024 * | 13,89 mld. 12,89 mld. | Omzet 2025 * | 14,91 mld. 13,84 mld. | Marktkapitalisatie | 103 mld. 96,01 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 4,26 mld. 3,96 mld. | Nettowinst (verlies) 2025 * | 4,54 mld. 4,21 mld. | EV/omzet 2024 * | 6,81 x |
Nettoliquiditeiten 2024 * | 8,91 mld. 8,27 mld. | Nettoliquiditeiten 2025 * | 12,78 mld. 11,86 mld. | EV/omzet 2025 * | 6,08 x |
K/w-verhouding 2024 * |
26,4
x | K/w-verhouding 2025 * |
24,7
x | Werknemers | 13.450 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 77,74% |
Recentste transcriptie over Regeneron Pharmaceuticals, Inc.
1 dag | -0,39% | ||
1 week | -0,57% | ||
Lopende maand | -0,37% | ||
1 maand | -2,54% | ||
3 maanden | +9,16% | ||
6 maanden | +15,33% | ||
Lopend jaar | +9,59% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 64 | 08-01-88 | |
Chief Executive Officer | 71 | 08-01-88 | |
Director of Finance/CFO | 54 | 01-01-03 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Christine Poon
BRD | Director/Board Member | 71 | 12-11-10 |
Chief Executive Officer | 71 | 08-01-88 | |
Michael Brown
BRD | Director/Board Member | 82 | 01-06-91 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
7.27% | 0 M€ | 0,00% | - | |
7.08% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 962,5 | -0,39% | 461 867 |
27-03-24 | 966,3 | +0,29% | 314 755 |
26-03-24 | 963,6 | +0,26% | 386 837 |
25-03-24 | 961,1 | -0,64% | 322 288 |
22-03-24 | 967,2 | -0,08% | 274 406 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,59% | 103 mld. | |
+2,73% | 108 mld. | |
+6,58% | 23,48 mld. | |
-12,59% | 21,93 mld. | |
-3,29% | 19,68 mld. | |
-35,36% | 18,37 mld. | |
-13,29% | 16,33 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,15 mld. | |
-6,78% | 10,2 mld. |